Evotec and Sartorius partner with start-up Curexsys on iPSC-based exosome approach
Exosomes are a promising novel approach for innovative regenerative therapies, as therapeutics in age-related conditions, but also for diagnostic purposes
10-Dec-2020 -
Evotec SE Sartorius announced that they have entered into a partnership with the recently established Curexsys GmbH, a Goettingen, Germany-based technology leader specialising in the emerging field of therapeutic exosomes.
Curexsys delivers a proprietary isolation technology for exosomes based on ...
exosomes
human mesenchymal stem cells